Physician profile
Brian R Smith
NPI 1629011564
$7,886.45
in general payments reported to CMS, 2019-2025
49 companies · $1,866 in 2025
The $1,866 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $925 · 2020: $450 · 2021: $998 · 2022: $1,694 · 2023: $1,260 · 2024: $693 · 2025: $1,866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,773 · Travel and Lodging: $1,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,773.02 |
| Travel and Lodging | $1,045.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,939.07 | 2021-2025 | Urolift, Barrigel |
| Astellas Pharma US INC | $729.98 | 2019-2024 | Xtandi, Myrbetriq |
| Abbvie INC. | $555.16 | 2019-2024 | Botox, Lupron Depot |
| Janssen Biotech, INC. | $460.02 | 2019-2024 | Erleada, Akeega |
| Pfizer INC. | $384.44 | 2019-2024 | |
| Amgen INC. | $323.28 | 2019-2023 | Xgeva |
| Bayer Healthcare Pharmaceuticals INC. | $265.11 | 2019-2023 | |
| Blue Earth Diagnostics | $253.39 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $245.98 | 2023-2025 | Orgovyx, Gemtesa |
| Myovant Sciences INC. | $218.94 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $205.57 | 2019-2023 | Xiaflex, Aveed, Edex |
| Merck Sharp & Dohme LLC | $169.35 | 2022-2023 | Keytruda, Welireg, Lynparza |
| Allergan, INC. | $152.49 | 2019-2022 | |
| Progenics Pharmaceuticals, INC. | $131.46 | 2022-2024 | Pylarify |
| Telix Pharmaceuticals | $127.49 | 2022 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.